Cipher Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,455
Closed -$1.33M 718
2017
Q2
$1.33M Buy
5,455
+1,886
+53% +$443K 0.1% 326
2017
Q1
$853K Buy
+3,569
New +$831K 0.06% 397
2016
Q4
Sell
-11,900
Closed -$2.74M 749
2016
Q3
$2.74M Buy
+11,900
New +$2.91M 0.17% 228
2015
Q3
Sell
-2,386
Closed -$724K 651
2015
Q2
$724K Buy
+2,386
New +$712K 0.1% 290
2014
Q1
Sell
-1,924
Closed -$323K 505
2013
Q4
$323K Buy
+1,924
New +$301K 0.22% 186

Other funds holding AGN

Cipher Capital's AGN Position: Q3 2017 in Review

Cipher Capital sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 5,455 shares — an estimated $1.33M sold.

Cipher Capital first reported a position in AGN in Q4 2013 and held it in 5 quarters. The position peaked at $2.74M in Q3 2016. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Cipher Capital reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Cipher Capital sold 5,455 Allergan plc shares in Q3 2017, an estimated $1.33M.
  • Cipher Capital first reported a position in Allergan plc in Q4 2013 and held it in 5 quarters.
  • Cipher Capital's Allergan plc position peaked at $2.74M in Q3 2016.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Cipher Capital's 13F filing for Q3 2017, filed 8 Nov 2017.